3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Ovarian Neoplasms
6
Pancreatic Neoplasms
4
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Urogenital Neoplasms
3
Stomach Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Gastrointestinal Neoplasms
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Rectal Neoplasms
2
Multiple Myeloma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Squamous Cell
2
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Sarcoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Myelodysplastic Syndromes
1
Interventions
Magnetic Resonance Spectroscopy
22
Temozolomide
17
Specimen Handling
13
X-Rays
9
Biopsy
9
Radiotherapy
8
Radiation
8
trametinib
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
6
Bevacizumab
6
larotrectinib
4
erdafitinib
4
dabrafenib
4
ulixertinib
3
palbociclib
3
abemaciclib
3
Surgical Procedures, Operative
3
Nivolumab
3
Cyclophosphamide
3
vorasidenib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
olaparib
2
mirdametinib
2
lutetium Lu 177 dotatate
2
ivosidenib
2
fluorodopa F 18
2
fludarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
aldesleukin
×
90 days
×
Clear all
No trials found.